Statistically enhanced spectral counting approach to TCDD cardiac toxicity in the adult zebrafish heart

Journal of Proteome Research

Volumn 12, Issue 7, 2013, Pages 3093-3103

  Zhang, Jiang ^a   Lanham, Kevin A ^b   Heideman, Warren ^a   Peterson, Richard E ^a   Li, Lingjun ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

cardiac toxicity; heart proteomics; mass spectrometry; quantitation; spectral counting; TCDD; zebrafish

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CHEMICAL PARAMETERS; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; HEART FAILURE; HEART HYPERTROPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; NORMALIZED SPECTRAL ABUNDANCE FACTOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SPECTRAL COUNTING; ZEBRA FISH;

ANIMALS; EMBRYO, NONMAMMALIAN; ENVIRONMENTAL POLLUTANTS; HEART; PROTEINS; PROTEOMICS; TETRACHLORODIBENZODIOXIN; ZEBRAFISH;

DANIO RERIO;

EID: 84879895528     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400312u     Document Type: Article

References (78)

1. Kociba, R. J.; Schwetz, B. A. Toxicity of 2,3,7,8-tetrachlorodibenzo- para-dioxin (TCDD) Drug Metab. Rev. 1982, 13 (3) 387-406
2. Lilienfeld, D. E.; Gallo, M. A. 2,4-D, 2,4,5-T, and 2,3,7,8-TCDD-An Overview Epidemiol. Rev. 1989, 11, 28-58
3. Skene, S. A.; Dewhurst, I. C.; Greenberg, M. Polychlorinated dibenzo- para -dioxins and polychlorinated dibenzofurans-the risks to human health-a review Hum. Toxicol. 1989, 8 (3) 173-203
4. McNulty, W. P. Fetotoxicity of 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) for Rhesus Macaques (Macaca-mulatta) Am. J. Primatol. 1984, 6 (1) 41-47
5. Hassoun, E. A.; Walter, A. C.; Alsharif, N. Z.; Stohs, S. J. Modulation of TCDD-induced fetotoxicity and oxidative stress in embryonic and placental tissues of C57BL/6J mice by vitamin E succinate and ellagic acid Toxicology 1997, 124 (1) 27-37
6. Elizondo, G.; Mejia-Garcia, A.; Sanchez-Ocampo, E.; Reyes-Hernandez, O.; Shibayama, M. TCDD potentiate CCl4 hepatotoxicity effects by increasing CYP2E1 hepatic levels. Role of aryl hydrocarbon receptor Drug Metab. Rev. 2009, 41, 86
7. Seo, S. H.; Ryu, Y. M.; Kim, K. N.; Kim, H. W.; Kim, Y. R.; Lee, S. H.; Won, N. H.; Kim, M. K. TCDD(2,3,7,8,-Tetrachlorodibenzo-p-dioxin)-induced hepatotoxicity Mol. Cell. Toxicol. 2007, 3 (4) 52
8. Sherr, D. H. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and long term immunologic memory Toxicol. Sci. 2004, 79 (2) 211-213
9. Kerkvliet, N. I. Recent advances in understanding the mechanisms of TCDD immunotoxicity Int. Immunopharmacol. 2002, 2 (2-3) 277-291
10. LaMont Bryant, P.; Schmid, J. E.; Fenton, S. E.; Buckalew, A. R.; Abbott, B. D. Teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the expression of EGF and/or TGF-alpha Toxicol. Sci. 2001, 62 (1) 103-114
11. Yasuda, M.; Igarashi, E.; Datu, A. R.; Igawa, H. Teratogenicity of 2,3,7,8-tetracholorodibenzo-para-dioxin (TCDD) in JCL-ICR Mice Teratology 1986, 34 (3) 454-455
12. Johnson, E. S. Important aspects of the evidence for TCDD carcinogenicity in man Environ. Health Perspect. 1993, 99, 383-390
13. Huff, J.; Lucier, G.; Tritscher, A. Carcinogenicity of TCDD-experimental, mechanistic, and epidemiologic evidence Annu. Rev. Pharmacol. Toxicol. 1994, 34, 343-372
14. Johnson, E. S. Human exposure to 2,3,7,8-TCDD and risk of cancer Crit. Rev. Toxicol. 1991, 21 (6) 451-63
15. Sielken, R. L. Quantitative cancer risk assessments for 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) Food Chem. Toxicol. 1987, 25 (3) 257-267
16. Cheung, M. O.; Peterson, R. E.; Gilbert, E. F. Cardiovascular teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in chick-embryo Teratology 1980, 21 (2) A34
17. Jokinen, M. P.; Walkers, N. J.; Brix, A. E.; Sells, D. M.; Nyska, A. Exacerbation of cardiovascular patholgies in female Sprague-Dawley rats following chronic treatment with 3,3,4,4,5-pentachlorobiphenyl (PCB126) or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) Toxicol. Sci. 2003, 72, 142
18. Mehta, V.; Peterson, R. E.; Heideman, W. 2,3,7,8-Tetrachlorodibenzo-p- dioxin exposure prevents cardiac valve formation in developing zebrafish Toxicol. Sci. 2008, 104 (2) 303-311
19. Carney, S. A.; Prasch, A. L.; Heideman, W.; Peterson, R. E. Understanding dioxin developmental toxicity using the zebrafish model Birth Defects Res., Part A 2006, 76 (1) 7-18
20. Handley-Goldstone, H. M.; Grow, M. W.; Stegeman, J. J. Cardiovascular gene expression profiles of dioxin exposure in zebrafish embryos Toxicol. Sci. 2005, 85 (1) 683-693
21. Antkiewicz, D. S.; Burns, C. G.; Carney, S. A.; Peterson, R. E.; Heideman, W. Heart malformation is an early response to TCDD in embryonic zebrafish Toxicol. Sci. 2005, 84 (2) 368-377
22. Carney, S. A.; Chen, J.; Burns, C. G.; Xiong, K. M.; Peterson, R. E.; Heideman, W. Aryl hydrocarbon receptor activation produces heart-specific transcriptional and toxic responses in developing zebrafish Mol. Pharmacol. 2006, 70 (2) 549-561
23. Ong, S. E.; Foster, L. J.; Mann, M. Mass spectrometric-based approaches in quantitative proteomics Methods 2003, 29 (2) 124-130
24. Ong, S. E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D. B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics Mol. Cell. Proteomics 2002, 1 (5) 376-386
25. Liu, H.; Sadygov, R. G.; Yates, J. R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics Anal. Chem. 2004, 76 (14) 4193-4201
26. 2-labeling in quantitative proteomic strategies: a status report J. Proteome Res. 2009, 8 (5) 2140-2143
27. Yao, X. D.; Afonso, C.; Fenselau, C. Dissection of proteolytic O-18 labeling: endoprotease-catalyzed O-16-to-O-18 exchange of truncated peptide substrates J. Proteome Res. 2003, 2 (2) 147-152
28. Dong, X.; Xiong, L.; Jiang, X.; Wang, Y. Quantitative proteomic analysis reveals the perturbation of multiple cellular pathways in jurkat-T cells induced by doxorubicin J. Proteome Res. 2010, 9 (11) 5943-5951
29. Wang, P.; Lo, A.; Young, J. B.; Song, J. H.; Lai, R.; Kneteman, N. M.; Hao, C.; Li, L. Targeted quantitative mass spectrometric identification of differentially expressed proteins between bax-expressing and deficient colorectal carcinoma cells J. Proteome Res. 2009, 8 (7) 3403-3414
30. De Souza, A. G.; MacCormack, T. J.; Wang, N.; Li, L.; Goss, G. G. Large-scale proteome profile of the zebrafish (Danio rerio) gill for physiological and biomarker discovery studies Zebrafish 2009, 6 (3) 229-238
31. Zybailov, B.; Mosley, A. L.; Sardiu, M. E.; Coleman, M. K.; Florens, L.; Washburn, M. P. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae J. Proteome Res. 2006, 5 (9) 2339-2347
32. Lundgren, D. H.; Hwang, S.-I.; Wu, L.; Han, D. K. Role of spectral counting in quantitative proteomics Expert Rev. Proteomics 2010, 7 (1) 39-53
33. Zybailov, B.; Coleman, M. K.; Florens, L.; Washburn, M. P. Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling Anal. Chem. 2005, 77 (19) 6218-6224
34. Paoletti, A. C.; Parmely, T. J.; Tomomori-Sato, C.; Sato, S.; Zhu, D. X.; Conaway, R. C.; Conaway, J. W.; Florens, L.; Washburn, M. P. Quantitative proteomic analysis of distinct mammalian Mediator complexes using normalized spectral abundance factors Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (50) 18928-18933
35. Pavelka, N.; Fournier, M. L.; Swanson, S. K.; Pelizzola, M.; Ricciardi-Castagnoli, P.; Florens, L.; Washburn, M. P. Statistical similarities between transcriptomics and quantitative shotgun proteomics data Mol. Cell. Proteomics 2008, 7 (4) 631-644
36. Westerfield, M., The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Brachydanio rerio), 2 nd ed.; University of Oregon Press: Eugene, OR, 1993.
37. Lanham, K. A.; Peterson, R. E.; Heideman, W. Sensitivity to dioxin decreases as zebrafish mature Toxicol. Sci. 2012, 127 (2) 360-370
38. Zhang, Y.; Wen, Z.; Washburn, M. P.; Florens, L. Refinements to label free proteome quantitation: how to deal with peptides shared by multiple proteins Anal. Chem. 2010, 82 (6) 2272-2281
39. Fermin, D.; Basrur, V.; Yocum, A. K.; Nesvizhskii, A. I. Abacus: A computational tool for extracting and pre-processing spectral count data for label-free quantitative proteomic analysis Proteomics 2011, 11 (7) 1340-1345
40. Ishimura, R.; Ohsako, S.; Kawakami, T.; Sakaue, M.; Aoki, Y.; Tohyama, C. Altered protein profile and possible hypoxia in the placenta of 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed rats Toxicol. Appl. Pharmacol. 2002, 185 (3) 197-206
41. Carpi, D.; Korkalainen, M.; Airoldi, L.; Fanelli, R.; Hakansson, H.; Muhonen, V.; Tuukkanen, J.; Viluksela, M.; Pastorelli, R. Dioxin-sensitive proteins in differentiating osteoblasts: effects on bone formation in vitro Toxicol. Sci. 2009, 108 (2) 330-343
42. Fletcher, N.; Wahlstrom, D.; Lundberg, R.; Nilsson, C. B.; Nilsson, K. C.; Stockling, K.; Hellmold, H.; Hakansson, H. 2,3,7,8-Tetrachlorodibenzo-p- dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study Toxicol. Appl. Pharmacol. 2005, 207 (1) 1-24
43. Tabb, D. L.; Vega-Montoto, L.; Rudnick, P. A.; Variyath, A. M.; Ham, A.-J. L.; Bunk, D. M.; Kilpatrick, L. E.; Billheimer, D. D.; Blackman, R. K.; Cardasis, H. L.; Carr, S. A.; Clauser, K. R.; Jaffe, J. D.; Kowalski, K. A.; Neubert, T. A.; Regnier, F. E.; Schilling, B.; Tegeler, T. J.; Wang, M.; Wang, P.; Whiteaker, J. R.; Zimmerman, L. J.; Fisher, S. J.; Gibson, B. W.; Kinsinger, C. R.; Mesri, M.; Rodriguez, H.; Stein, S. E.; Tempst, P.; Paulovich, A. G.; Liebler, D. C.; Spiegelman, C. Repeatability and reproducibility in proteomic identifications by liquid chromatography tandem mass spectrometry J. Proteome Res. 2009, 9 (2) 761-776
44. Wang, H.; Chang-Wong, T.; Tang, H.-Y.; Speicher, D. W. Comparison of extensive protein fractionation and repetitive LC-MS/MS analyses on depth of analysis for complex proteomes J. Proteome Res. 2009, 9 (2) 1032-1040
45. Peterson, R. E.; Madhukar, B. V.; Yang, K. H.; Matsumura, F. Depression of adenosine-triphosphatase activities in isolated liver surface-membranes of 2,3,7,8-tetrachlorodibenzo-para-dioxin-treated rats-correlation with effects on ouabain biliary-excretion and bile-flow J. Pharmacol. Exp. Ther. 1979, 210 (2) 275-282
46. Schmidt-Schweda, S. H.; Linnemuller, S.; Hasenfuss, G.; Prestle, J.; Pieske, B.; Goebel, J.; Hellige, N. Adenovirus mediated overexpression of Na+/Ca2+-exchanger in rabbit cardiomyocytes impairs force-frequency behavior and Ca2+-cycling Eur. Heart J. 2001, 22, 539
47. 2+ exchanger J. Physiol.-London 1998, 512 (3) 651-667
48. Schillinger, W.; Ohler, A.; Emami, S.; Muller, F.; Christians, C.; Janssen, P. M. L.; Kogler, H.; Teucher, N.; Pieske, B.; Seidler, T.; Hasenfuss, G. The functional effect of adenoviral Na+/Ca2+ exchanger overexpression in rabbit myocytes depends on the activity of the Na+/K+-ATPase Cardiovasc. Res. 2003, 57 (4) 996-1003
49. Canga, L.; Paroli, L.; Blanck, T. J. J.; Silver, R. B.; Rifkind, A. B. 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases cardiac myocyte intracellular calcium and progressively impairs ventricular contractile responses to isoproterenol and to calcium in chick-embryo hearts Mol. Pharmacol. 1993, 44 (6) 1142-1151
50. Camors, E.; Charue, D.; Trouve, P.; Monceau, V.; Loyer, X.; Russo-Marie, F.; Charlemagne, D. Association of annexin A5 with Na+/Ca2+ exchanger and caveolin-3 in non-failing and failing human heart J. Mol. Cell. Cardiol. 2006, 40 (1) 47-55
51. Moraru, I. I.; Syrbu, S.; Zecevic, N.; Hager, W. D.; Watras, J.; Messineo, F. An antibody to annexin V blocks Ca2+-dependent ATPase activity of sarcoplasmic reticulum in human failing hearts. In Cardiac Sarcoplasmic Reticulum Function and Regulation of Contractility; Annals of the New York Academy of Sciences, Volume 853; The New York Academy of Sciences: New York, 1998; 333-337.
52. Wood, Z. A.; Schröder, E.; Robin Harris, J.; Poole, L. B. Structure, mechanism and regulation of peroxiredoxins Trends Biochem. Sci. 2003, 28 (1) 32-40
53. Rhee, S. G.; Chae, H. Z.; Kim, K. Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling Free Radic. Biol. Med. 2005, 38 (12) 1543-1552
54. Wood, Z. A.; Schroder, E.; Harris, J. R.; Poole, L. B. Structure, mechanism and regulation of peroxiredoxins Trends Biochem. Sci. 2003, 28 (1) 32-40
55. Fontanesi, F.; Soto, I. C.; Horn, D.; Barrientos, A. Assembly of mitochondrial cytochrome c-oxidase, a complicated and highly regulated cellular process Am. J. Physiol.: Cell Physiol. 2006, 291 (6) C1129-C1147
56. Pecina, P.; Houstkova, H.; Hansikova, H.; Zeman, J.; Houstek, J. Genetic defects of cytochrome C oxidase assembly Physiol. Res. 2004, 53, S213-S223
57. Chmurzynska, A. The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism J. Appl. Genet. 2006, 47 (1) 39-48
58. Weisiger, R. A. Cytosolic fatty acid binding proteins catalyze two distinct steps in intracellular transport of their ligands Mol. Cell. Biochem. 2002, 239 (1-2) 35-43
59. Halestrap, A.; Meredith, D. The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond Pflügers Archiv. Eur. J. Physiol. 2004, 447 (5) 619-628
60. Wang, Q.; Morris, M. E. The role of monocarboxylate transporter 2 and 4 in the transport of gamma-hydroxybutyric acid in mammalian cells Drug Metab. Dispos. 2007, 35 (8) 1393-1399
61. Sack, M. N.; Kelly, D. P. The energy substrate switch during development of heart failure: Gene regulatory mechanisms (Review) Int. J. Mol. Med. 1998, 1 (1) 17-24
62. Sack, M. N.; Rader, T. A.; Kelly, D. P. Characterization of a gene regulatory pathway involved in the energy substrate switch during development of cardiac hypertrophy in transgenic mice J. Invest. Med. 1996, 44 (7) A366
63. Sack, M. N.; Rader, T. A.; Schaffer, J. E.; Rockman, H. A.; Kelly, D. P. Expression of genes involved in myocardial fatty acid utilization and glycolysis is regulated in parallel with the energy substrate switch in the pressure overloaded ventricle Circulation 1996, 94 (8) 1791-1791
64. Barger, P. M.; Kelly, D. P. Fatty acid utilization in the hypertrophied and failing heart: Molecular regulatory mechanisms Am. J. Med. Sci. 1999, 318 (1) 36-42
65. Gunning, P.; O'Neill, G.; Hardeman, E. Tropomyosin-based regulation of the actin cytoskeleton in time and space Physiol. Rev. 2008, 88 (1) 1-35
66. Wolska, B. M.; Wieczorek, D. F. The role of tropomyosin in the regulation of myocardial contraction and relaxation Pflugers Archiv. Eur. J. Physiol. 2003, 446 (1) 1-8
67. Gordon, A. M.; Regnier, M.; Homsher, E. Skeletal and cardiac muscle contractile activation: Tropomyosin "rocks and rolls" News Physiol. Sci. 2001, 16, 49-55
68. Elsaleh, S. C.; Warber, K. D.; Potter, J. D. The role of tropomyosin troponin in the regulation of skeletal-muscle contraction J. Muscle Res. Cell Motil. 1986, 7 (5) 387-404
69. Solaro, R. J.; Rarick, H. M. Troponin and tropomyosin-Proteins that switch on and tune in the activity of cardiac myofilaments Circ. Res. 1998, 83 (5) 471-480
70. Zot, A. S.; Potter, J. D. Structural aspects of troponin-tropomyosin regulation of skeletal-muscle contraction Annu. Rev. Biophys. Biophys. Chem. 1987, 16, 535-559
71. Perry, S. V. Vertebrate tropomyosin: distribution, properties and function J. Muscle Res. Cell Motil. 2001, 22 (1) 5-49
72. Gunning, P. W.; Schevzov, G.; Kee, A. J.; Hardeman, E. C. Tropomyosin isoforms: divining rods for actin cytoskeleton function Trends Cell Biol. 2005, 15 (6) 333-341
73. Leesmiller, J. P.; Helfman, D. M. The molecular-basis for tropomyosin isoform diversity Bioessays 1991, 13 (9) 429-437
74. Moraczewska, J. [Role of tropomyosin isoforms in diversification of actin filaments functions] Postepy Biochem. 2009, 55 (2) 201-206
75. Tardiff, J. C. Sarcomeric proteins and familial hypertrophic cardiomyopathy: Linking mutations in structural proteins to complex cardiovascular phenotypes Heart Failure Rev. 2005, 10 (3) 237-248
76. Alcalai, R.; Seidman, J. G.; Seidman, C. E. Genetic basis of hypertrophic cardiomyopathy: From bench to the clinics J. Cardiovasc. Electrophysiol. 2008, 19 (1) 104-110
77. Laing, N. G. Congenital myopathies Curr. Opin. Neurol. 2007, 20 (5) 583-589
78. Muthuchamy, M.; Boivin, G. P.; Grupp, I. L.; Wieczorek, D. F. [beta]-Tropomyosin overexpression induces severe cardiac abnormalities J. Mol. Cell. Cardiol. 1998, 30 (8) 1545-1557